Colonic Tuft Cells: The Less-Recognized Therapeutic Targets in Inflammatory Bowel Disease and Colorectal Cancer

Area of Science:

• Gastroenterology
• Immunology
• Cell Biology

Background:

• Tuft cells are specialized chemosensory cells in the digestive tract.
• They possess immune effector functions and are crucial for defense against parasites.
• Their roles in intestinal homeostasis and disease are increasingly recognized.

Purpose of the Study:

• To review the pathogenic and therapeutic roles of colonic tuft cells.
• To focus on their immunomodulatory actions in inflammatory bowel disease (IBD) and colorectal cancer (CRC).
• To evaluate their potential as therapeutic targets.

Main Methods:

• Literature review of studies on tuft cell characteristics and functions.
• Analysis of tuft cell involvement in IBD pathogenesis and progression.
• Investigation of tuft cell contributions to colorectal cancer development and immune response.

Main Results:

• Tuft cells contribute to intestinal barrier integrity, repair, and regeneration in IBD.
• They exhibit complex immune-regulatory functions influencing intestinal homeostasis.
• In CRC, tuft cells can promote epithelial-to-mesenchymal transition and modulate anti-tumor immunity.

Conclusions:

• Colonic tuft cells have significant immunomodulatory roles in IBD and CRC.
• Their functions offer potential therapeutic targets for anti-inflammatory and anti-tumor strategies.
• Careful consideration of adverse immunomodulatory side effects is essential for therapeutic development.